Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
John Dent(Royal Adelaide Hospital), D. J. C. Shearman(Royal Adelaide Hospital), Enrico Solcia(Royal Adelaide Hospital), W D Reed, David J. Hetzel(South Australia Pathology), Malcolm Mackinnon(Royal Adelaide Hospital), Neville D. Yeomans(Royal Adelaide Hospital), F. M. Narielvala(Royal Adelaide Hospital)
Cited by 184
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
|Gastroenterology|1988|786
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
|Gastroenterology|2000|544
A genetic linkage map of the bovine genome
|Nature Genetics|1994|539